COMMUNIQUÉS West-GlobeNewswire

Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock and Warrants
04/04/2018
NEWTOWN, Pa., April 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) (“ Helius ” or the “ Company ”) announced today that it intends to offer and sell, subject to market conditions [...]
Global Autism Project Partners With Leading Technology and Behavioral Health Experts Rethink
04/04/2018
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Global Autism Project is excited to announce their new partnership with leading technology and behavioral health experts, Rethink Behavioral Health. In this collaboration, [...]
Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority
04/04/2018
Curetis ' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority Second market authorization for Unyvero Cartridges this year in Singapore Amsterdam, the Netherlands, and [...]
Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives
04/04/2018
Over 97% of Final Patient Visits in REDUCE-IT Completed or Scheduled for Near-Term Completion BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a [...]
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events
04/04/2018
On Track to Report REDUCE-IT Results Before the End of Q3 2018 BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the [...]
Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal
04/04/2018
Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal AKYNZEO®, containing netupitant 300mg and palonosetron 0.5mg, is used for prevention of [...]
Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today
04/04/2018
Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today Amsterdam, the Netherlands, San Diego, CA, USA, and [...]
RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment
04/04/2018
World’s Only Biology-Guided Radiation Therapy Could Help Millions More Patients Worldwide HAYWARD, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical, a medical technology company developing the first and only [...]
NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING
04/04/2018
Biohit Oyj Stock Exchange Release April 4, 2018 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held on Wednesday, April 25, 2018 starting at 5:00 pm [...]
CellaVision AB: Notice of 2018 Annual General Meeting of CellaVision (publ)
04/04/2018
The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on May 4, 2018 at 15.00 at CellaVision AB, Mobilvägen 12, Ideon in Lund, Sweden. Registration begins at 14:30. The [...]
Shire plc : Rule 2.9 Announcement
04/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 April 2018 Shire [...]
ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of Diabetic Macular Edema (DME)
04/04/2018
Press release Study results demonstrate safety and tolerability of THR-317 for intra-ocular use 30% of anti-VEGF treatment naïve patients had a 3 line or more (> or equal to 15 letters) gain in Best Corrected Visual [...]
CEO Of Twinlab, Naomi Whittel’s Premier book, GLOW15, is an instant New York Times and Wall Street Journal bestseller
04/04/2018
GLOW15 brings to the limelight a science-based plan featuring a Nobel Prize-winning process that will change the way we live New York, April 03, 2018 (GLOBE NEWSWIRE) -- – Glow15: A Science-Based Plan To Lose Weight, [...]
Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights
03/04/2018
- Recent initiation of STAR phase 3 trial in Choroideremia - - Begins 2018 with a cash position over $129 million - LEXINGTON, Mass. and LONDON, April 03, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ: [...]
New Patient-Centered Program Launched for New York Primary Care Practices
03/04/2018
NYS Patient-Centered Medical Home (NYS PCMH) Program Advances Primary Care, Addresses State’s Goals WASHINGTON, DC, April 03, 2018 (GLOBE NEWSWIRE) -- The National Committee for Quality Assurance (NCQA), creator of the [...]
Unum Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with Seattle Genetics
03/04/2018
CAMBRIDGE, Mass., April 03, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (“Unum Therapeutics”) (NASDAQ: UMRX ), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products [...]
Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge
03/04/2018
Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge First ever multiplex MDx test to be granted clearance by the FDA for this indication Commercial [...]
EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes
03/04/2018
Clinical Results Presented at the Southeastern Section of the American Urological Association Confirms HIFU's Safety, Efficacy and Benefits for Patients' Quality Of Life LYON, FRANCE, AUSTIN, TX -- APRIL 3, 2018 - EDAP [...]
BeyondSpring Files Its 2017 Annual Report on Form 20-F
03/04/2018
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focusing on the development of innovative cancer therapies, today announced that the [...]

Pages